fbpx

REQUEST A CONSULTATION

Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.
search
News

A New Honor for Prof. Arnon Nagler, President of the Hemato-Oncology Center at Sheba

Prof. Arnon Nagler Forbes
Prof. Arnon Nagler, the highly esteemed clinician and researcher was named among the leading hematologists in Israel according to Forbes magazine

Not unaccustomed to accolades and honors, Prof. Arnon Nagler was yet again recognized for his expertise and clinical excellence: this time by Forbes magazine, which named him one of Israel’s leading hematologists.

A pioneer of non-myeloablative and reduced intensity\toxicity allogeneic transplantations for both malignant and non-malignant tumors, Prof. Nagler has published hundreds of articles, reviews, and chapters in premier peer-reviewed journals, and has served as head of Sheba’s hematological array for the past 20 years. Notwithstanding, Prof. Nagler also maintains a senior teaching position at Tel-Aviv University, and has held prominent leadership positions in international cancer organizations throughout his extensive career.

Upon learning of this latest honor, Prof. Nagler offered the following remarks: “Allogeneic transplantations and cell immunotherapy are at the cutting edge of cancer care and constitute life-saving treatments for many patients. I am truly grateful for the privilege to dedicate my professional life towards developing these therapies.”

Related
Sheba Leverages ChatGPT
Accelerating Diagnostics: ChatGPT Results Aligned with Breast Cancer Board Recommendations
Recently, several distinguished Sheba clinicians were impressed by the tool’s capabilities. The group, which included Dr. Vera Sorin, Dr. Eyal Klang, Dr. Miri Sklair-Levy, Prof.…
Read More
Sheba and Vidac
Novel Drug Set to Improve CAR T-Cell Therapy Effectiveness
While many medical centers around the world depend on external labs to genetically engineer patient T-cells, a process that can take up to a few…
Read More
Sheba Named Global Oncology Leader
by Newsweek Magazine
Dedicated to providing those in need across the globe ‘Hope Without Boundaries,’ Sheba treats patients from more than 100 countries each year, employing the latest…
Read More